Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents

C. Kestens; M.G.H. van Oijen; C.L. Mulder; A.A. van Bodegraven; G. Dijkstra; D. de Jong; C. Ponsioen; B.A. van Tuyl; P.D. Siersema; H.H. Fidder; B. Oldenburg

Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents

Translated title of the contribution: Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents

C. Kestens
, M.G.H. van Oijen
, C.L. Mulder
, A.A. van Bodegraven
, G. Dijkstra
, D. de Jong
, C. Ponsioen
, B.A. van Tuyl
, P.D. Siersema
, H.H. Fidder
, B. Oldenburg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents
Original language	Undefined/Unknown
Pages (from-to)	826-831
Number of pages	6
Journal	Clinical Gastroenterology and Hepatology
Volume	11
Issue number	7
Publication status	Published - 2013

Cite this

Kestens, C., van Oijen, M. G. H., Mulder, C. L., van Bodegraven, A. A., Dijkstra, G., de Jong, D., Ponsioen, C., van Tuyl, B. A., Siersema, P. D., Fidder, H. H., & Oldenburg, B. (2013). Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents. Clinical Gastroenterology and Hepatology, 11(7), 826-831.

@article{c79c7179391d4875a169764d755c4786,

title = "Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents",

author = "C. Kestens and \{van Oijen\}, M.G.H. and C.L. Mulder and \{van Bodegraven\}, A.A. and G. Dijkstra and \{de Jong\}, D. and C. Ponsioen and \{van Tuyl\}, B.A. and P.D. Siersema and H.H. Fidder and B. Oldenburg",

year = "2013",

language = "Undefined/Unknown",

volume = "11",

pages = "826--831",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders",

number = "7",

}

Kestens, C, van Oijen, MGH, Mulder, CL, van Bodegraven, AA, Dijkstra, G, de Jong, D, Ponsioen, C, van Tuyl, BA, Siersema, PD, Fidder, HH & Oldenburg, B 2013, 'Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents', Clinical Gastroenterology and Hepatology, vol. 11, no. 7, pp. 826-831.

TY - JOUR

T1 - Adalimumab and infliximab are equally effective for Crohn's disease in patient not previously treated with anti-tumor necrosis factor-a agents

AU - Kestens, C.

AU - van Oijen, M.G.H.

AU - Mulder, C.L.

AU - van Bodegraven, A.A.

AU - Dijkstra, G.

AU - de Jong, D.

AU - Ponsioen, C.

AU - van Tuyl, B.A.

AU - Siersema, P.D.

AU - Fidder, H.H.

AU - Oldenburg, B.

PY - 2013

Y1 - 2013

M3 - Article

SN - 1542-3565

VL - 11

SP - 826

EP - 831

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 7

ER -